Literature DB >> 9273977

Ultrastructural localization of insulin-like growth factor-2 (IGF-2) to the secretory granules of insulin cells: a study in normal and diabetic (GK) rats.

A Höög1, W Hu, S M Abdel-Halim, S Falkmer, L Qing, L Grimelius.   

Abstract

By using biochemical and light-microscopical techniques, insulin-like growth factor-2 (IGF-2) has recently been found in adult pancreas, co-localized immunohistochemically with insulin in the islet B-cells. The purpose of this study was to trace IGF-2 immunoreactivity (IR) at the ultrastructural level in normal and diabetic Goto-Kakizaki (GK) rats. Using a pre-embedding technique and immuno-gold-silver staining, IGF-2 antibody binding was localized exclusively to the halo of a subset of secretory beta-granules in normal rats. Insulin IR occurred more frequently in the granules. GK rats had, in addition to normal-looking islets, some islets with irregular shape and an increased amount of fibrous tissue, so-called "starfish-shaped" islets. In these, beta-granules were usually found, but most of the B-cells were also occupied by large, usually electron-translucent vesicles, some resembling crinophagic bodies, i.e., the sign of intracellular degradation of secretory granules. In starfish-shaped islets, IGF-2 IR was localized to the halo of beta-granules, as in GK islets with normal appearance. Occasionally, IGF-2 IR was also found in the cytoplasm and even in adjacent fibroblasts. Insulin IR was restricted to beta-granules. Because the lysosomes have IGF-2 receptors, the presence of IGF-2 peptide in secretory granules could explain why some granules are guided to lysosomes for degradation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9273977     DOI: 10.3109/01913129709021946

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  7 in total

1.  Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion.

Authors:  C M Buchanan; A R Phillips; G J Cooper
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

2.  Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression.

Authors:  Marion Cornu; Honey Modi; Dan Kawamori; Rohit N Kulkarni; Magali Joffraud; Bernard Thorens
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

3.  Immunohistochemical and electron-microscopic observation of beta-cells in pancreatic islets of spontaneously diabetic Goto-Kakizaki rats.

Authors:  Kazuko Momose; Shin Nunomiya; Masanori Nakata; Toshihiko Yada; Motoshi Kikuchi; Takashi Yashiro
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

4.  Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.

Authors:  J C Devedjian; M George; A Casellas; A Pujol; J Visa; M Pelegrín; L Gros; F Bosch
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop.

Authors:  Marion Cornu; Jiang-Yan Yang; Evrim Jaccard; Carine Poussin; Christian Widmann; Bernard Thorens
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

6.  Acylated and desacylated ghrelin, preptin, leptin, and nesfatin-1 Peptide changes related to the body mass index.

Authors:  Yusuf Ozkan; Esra Suay Timurkan; Suleyman Aydin; Ibrahim Sahin; Mustafa Timurkan; Cihan Citil; Mehmet Kalayci; Musa Yilmaz; Aziz Aksoy; Zekiye Catak
Journal:  Int J Endocrinol       Date:  2013-11-25       Impact factor: 3.257

7.  PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery.

Authors:  Reshma D Ramracheya; Laura J McCulloch; Anne Clark; David Wiggins; Helene Johannessen; Magnus Kringstad Olsen; Xing Cai; Chun-Mei Zhao; Duan Chen; Patrik Rorsman
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.